Barclays Maintains Overweight on MACOM Technology Solns, Raises Price Target to $400

Benzinga Newsdesk www.benzinga.com Positive 78.6%

Neg 0% Neu 0% Pos 78.6%

Barclays analyst Tom O'Malley maintains MACOM Technology Solns (NASDAQ:MTSI) with a Overweight and raises the price target from $265 to $400.